SOLEUS CAPITAL MASTER FUND, L.P. 13D and 13G filings for Apollo Endosurgery, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 08:14 am Sale | 2022-12-31 | 13G | Apollo Endosurgery, Inc. APEN | SOLEUS CAPITAL MASTER FUND, L.P. | 0 0.000% | -2,295,100 (Position Closed) | Filing |
| 2022-02-10 5:01 pm Purchase | 2021-12-31 | 13G | Apollo Endosurgery, Inc. APEN | SOLEUS CAPITAL MASTER FUND, L.P. | 2,295,100 5.800% | 209,603 (+10.05%) | Filing |
| 2021-12-20 5:01 pm Purchase | 2021-12-14 | 13G | Apollo Endosurgery, Inc. APEN | SOLEUS CAPITAL MASTER FUND, L.P. | 2,085,497 5.300% | 2,085,497 (New Position) | Filing |